Liver carcinoma CT | Liver carcinoma MRI
Item
1. hepatocellular carcinoma with histological or evidence or typical findings by ct or mri.
boolean
C2239176 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C2239176 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
Tumors Resectable | Tumor thrombus First Branch of portal vein | Tumor thrombus Main portal venous trunk
Item
2. surgically resectable tumors with tumor thrombus in first branch or main trunk of portal vein.
boolean
C0027651 (UMLS CUI [1,1])
C1514888 (UMLS CUI [1,2])
C3163918 (UMLS CUI [2,1])
C0226736 (UMLS CUI [2,2])
C0205435 (UMLS CUI [2,3])
C3163918 (UMLS CUI [3,1])
C1183135 (UMLS CUI [3,2])
Age
Item
3. 20 years old or more.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
4. eastern cooperative oncology group performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
5. life expectancy of at least 6 months at the pre-treatment evaluation.
boolean
C0023671 (UMLS CUI [1])
Child-Pugh Classification
Item
6. child-pugh class a or b.
boolean
C2347612 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
7. adequate bone marrow, liver and renal function, as assessed by the following laboratory requirements.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
White Blood Cell Count procedure | Neutrophil count | Hemoglobin measurement | Platelet Count measurement | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Creatinine measurement, serum | Creatinine clearance measurement
Item
white blood cell count >= 2000/microliter, neutrophil >= 1000/microliter, hemoglobin >= 9.0 g/dl, platelet count >= 75000/microliter, total bilirubin <= 1.5mg/dl, aspartate aminotransferase(ast) /alanine aminotransferase(alt) <= 150 iu/l, serum creatinine <= 1.2mg/dl, creatinine clearance >= 60 ml/min
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
C0373595 (UMLS CUI [9])
Combination Liver carcinoma Cholangiocarcinoma
Item
1. histological diagnosed combined hepatocellular and cholangiocellular carcinoma.
boolean
C0205195 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C0206698 (UMLS CUI [1,3])
Tumor Spread Extrahepatic | Involvement with Prognosis
Item
2. extrahepatic tumor spread which affects patient's prognosis.
boolean
C0027651 (UMLS CUI [1,1])
C0332261 (UMLS CUI [1,2])
C1517058 (UMLS CUI [1,3])
C1314939 (UMLS CUI [2,1])
C0033325 (UMLS CUI [2,2])
Hepatic Encephalopathy
Item
3. hepatic encephalopathy
boolean
C0019151 (UMLS CUI [1])
Communicable Diseases | Exception Hepatitis B | Exception Hepatitis C
Item
4. active infections except for hepatitis b virus(hbv) and hepatitis c virus(hcv).
boolean
C0009450 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0019196 (UMLS CUI [3,2])
Severe complication | Pneumonia, Interstitial | Heart failure | Kidney Failure | Liver Failure | Ileus | Diabetic - poor control
Item
5. sever complications (interstitial pneumonia, heart failure, renal failure, liver failure, ileus, incontrollable diabetes mellitus, and so on)
boolean
C3495031 (UMLS CUI [1])
C0206061 (UMLS CUI [2])
C0018801 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
C0085605 (UMLS CUI [5])
C1258215 (UMLS CUI [6])
C0421258 (UMLS CUI [7])
Malignant Neoplasm Double
Item
6. active double cancer
boolean
C0006826 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
Pregnancy | Pharmaceutical Preparations Affecting Drug absorption | Therapy Affecting Drug absorption | Pharmaceutical Preparations Affecting Pharmacokinetics | Therapeutic procedure Affecting Pharmacokinetics
Item
7. pregnancy 8-10) medication or treatment that may affect to the absorption of drug or pharmacokinetics.
boolean
C0032961 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0678745 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0678745 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C0031327 (UMLS CUI [4,3])
C0087111 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0031327 (UMLS CUI [5,3])
Eligibility Criteria Additional
Item
11) others, in the investigator's judgment.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])